“…6 In Hungary, using ATP III criteria, the prevalence of MS among males and females in the age groups of 20-34, 35-54 and 55-69 years is 12%, 6% and 30%, and 26%, 42 % and 43%, respectively. 7 These results are very similar to prevalence data measured in other developed countries. 6,8,9 The co-incidence of the above mentioned cardiovascular risk factors in complex metabolic failure worsens the life expectancies of affected people.…”